PCI invests in capacity for opioid packaging following legislation
PCI Pharma Services will make an additional investment into infrastructure needed for the use of blister packaging controlled substances.
PCI Pharma Services will make an additional investment into infrastructure needed for the use of blister packaging controlled substances.
FDA provided an update on its valsartan contamination investigation and suggested it had discovered two possible causes of the carcinogenic impurities.
Novartis joined industry associations in expressing concerns over the impact that a ‘hard’ or ‘disorderly’ Brexit could have on the life sciences sector.
The industry looking to new technologies and cross-industry collaboration to tackle declining ROI – as R&D has become an area in which companies can no longer “go it alone,” according to a new report.
Quorum Review IRB is collaborating with a global cancer research network to help improve clinical trial start-up and patient recruitment processes.
The Wasdell Group’s new EU headquarters in Dundalk, Ireland is set to commence operations later this year as part of the company’s “proactive contingency plan” ahead of Brexit.